These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 639831)
1. Bioavailability of norethindrone in human subjects. Okerholm RA; Peterson FE; Keeley FJ; Smith TC; Glazko AJ Eur J Clin Pharmacol; 1978 Mar; 13(1):35-9. PubMed ID: 639831 [TBL] [Abstract][Full Text] [Related]
2. Plasma levels of norethindrone after single oral dose administration of norethindrone and lynestrenol. Odlind V; Weiner E; Victor A; Johansson ED Clin Endocrinol (Oxf); 1979 Jan; 10(1):29-38. PubMed ID: 436304 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of norethindrone oenanthate in 5 women after a single dose of norethindrone oenanthate and estradiol valerate. Sang GW; Liu XH Zhongguo Yao Li Xue Bao; 1986 May; 7(3):255-9. PubMed ID: 2954375 [No Abstract] [Full Text] [Related]
4. Plasma concentrations of ethynyl oestradiol and norethindrone after oral administration to women. Pasqualini JR; Castellet R; Portois MC; Hill JL; Kincl FA J Reprod Fertil; 1977 Mar; 49(2):189-93. PubMed ID: 850209 [TBL] [Abstract][Full Text] [Related]
5. A randomized trial of three oral contraceptives: comparison of bleeding patterns by contraceptive types and steroid levels. Saleh WA; Burkman RT; Zacur HA; Kimball AW; Kwiterovich P; Bell WK Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1740-5; discussion 1745-7. PubMed ID: 8317516 [TBL] [Abstract][Full Text] [Related]
6. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis. Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419 [TBL] [Abstract][Full Text] [Related]
8. Kinetics of norethindrone in women. I. Radioimmunoassay and concentrations during multiple dosing. Back DJ; Breckenridge AM; Crawford FE; Mciver M; Orme ML; Park BK; Rowe PH; Smith E Clin Pharmacol Ther; 1978 Oct; 24(4):439-47. PubMed ID: 567550 [No Abstract] [Full Text] [Related]
9. Kinetics of norethindrone in women. II. Single-dose kinetics. Back DJ; Breckenridge AM; Crawford FE; Mciver M; Orme ML; Rowe PH; Smith E Clin Pharmacol Ther; 1978 Oct; 24(4):448-53. PubMed ID: 688734 [No Abstract] [Full Text] [Related]
10. First human exposure to exogenous single-dose oral estetrol in early postmenopausal women. Visser M; Holinka CF; Coelingh Bennink HJ Climacteric; 2008; 11 Suppl 1():31-40. PubMed ID: 18464021 [TBL] [Abstract][Full Text] [Related]
12. Rate of metabolism of norethisterone in women from different populations. Fotherby K; Shrimanker K; Abdel-Rahman HA; Toppozada HK; de Souza JC; Coutinho EM; Koetsawang S; Nukulkarn P; Sheth UK; Mapa MK; Gopalan S; Plunkett ER; Brenner PF; Hickey MV; Grech ES; Lichtenberg R; Gual C; Molina R; Gomez-Rogers C; Kwon E; Kim SW; Chan T; Ratnam SS; Landgren BM; Shearman RP Contraception; 1979 Jan; 19(1):39-45. PubMed ID: 428223 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of norethindrone acetate in women after the insertion of a single subdermal implant releasing norethindrone acetate. Singh H; Uniyal JP; Jha P; Takker D; Murguesan K; Hingorani V; Laumas KR Acta Endocrinol (Copenh); 1982 Feb; 99(2):302-8. PubMed ID: 7058686 [TBL] [Abstract][Full Text] [Related]
14. Selected aspects of the pharmacokinetics and metabolism of ethinyl estrogens and their clinical implications. Goldzieher JW Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):318-22. PubMed ID: 2196804 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic parameters of terbutaline in healthy man. An overview. Nyberg L Eur J Respir Dis Suppl; 1984; 134():149-60. PubMed ID: 6586475 [TBL] [Abstract][Full Text] [Related]
16. Influence of aspirin on the pharmacokinetics of norethindrone. Gomaa AA; Makarm MH Contraception; 1987 Jun; 35(6):611-8. PubMed ID: 3665485 [TBL] [Abstract][Full Text] [Related]
17. Metabolism of oral contraceptive drugs. The formation and disappearance of metabolites of norethindrone and mestranol after intravenous and oral administration. Mills TM; Lin TJ; Braselton WE; Ellegood JO; Mahesh VB Am J Obstet Gynecol; 1976 Dec; 126(8):987-92. PubMed ID: 998688 [TBL] [Abstract][Full Text] [Related]
18. Contraceptive efficacy, pharmacokinetics, and safety of Annuelle biodegradable norethindrone pellet implants. Raymond EG; Singh M; Archer DF; Saxena BB; Baker J; Cole D Fertil Steril; 1996 Dec; 66(6):954-61. PubMed ID: 8941061 [TBL] [Abstract][Full Text] [Related]
19. Rectal ropivacaine is absorbed proportionally to the dose, with low intraindividual variability. Arlander E; Sjövall J; Sörstad J; Norsten-Höög C; Gustafsson LL Br J Clin Pharmacol; 2003 Jan; 55(1):14-22. PubMed ID: 12534636 [TBL] [Abstract][Full Text] [Related]
20. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics. Scheffler MR; Colburn W; Kook KA; Thomas SD Clin Pharmacol Ther; 1999 May; 65(5):483-90. PubMed ID: 10340913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]